Insel Gruppe AG, University Hospital Bern: Cerebral Infarction trials

The registry lists 11 Cerebral Infarction studies with Insel Gruppe AG, University Hospital Bern as lead sponsor. 5 are open to participants now and 0 have results posted.

No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial FibrillationRecruitingNCT06954610
• Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsRecruitingNCT06556446
• Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 StudyRecruitingNCT06100718
• Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain InfarctionsRecruitingNCT05685069
• Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic LesionsRecruitingNCT04449523
• Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral VasospasmCompletedNCT04988932Not applicable
• Ischemic Stroke, Obesity and ThrombolysisCompletedNCT04196894
• Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy.CompletedNCT03496064
• Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded TrialCompletedNCT03148457Not applicable
• Dynamic Contrast-enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Acute Ischemic StrokeCompletedNCT02415972
• Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke RegistryCompletedNCT00811538